What does Kisspeptin-10 do? Benefits and evidence
A short-acting experimental peptide that triggers reproductive hormone release.
Also called: KP-10, KP10, Kisspeptin 112-121, Metastin 45-54, NSC 741805.
Reproductive axis peptides · KISS1 receptor agonist.
Kisspeptin-10 triggers reproductive hormone release, but home injection benefits and long-term safety remain unproven. Libido and IVF findings for kisspeptin-54 do not establish benefits for kisspeptin-10. Small studies found hormone changes, sometimes including testosterone. A 2026 study tested under-skin infusions for up to 12 days in healthy men. It has no approved dose.
- In small studies in men, an IV dose raised testosterone and LH, the hormone that signals the testes. (Studied in a trial)
- In a small study, pump doses under the skin kept their hormone effect for 12 days. (Studied in a trial)
- Studied as a test of the brain's reproductive signal in delayed puberty and low sex hormone conditions. (Studied in a trial)
- People report stronger libido or fuller testes, but no one confirmed it with tests. (Reported by users)
Uses in the sources
- Studied as a probe of GnRH function in hypogonadism and delayed puberty. Some congenital cases do not respond. (Studied in a trial) (source)
- Studied for hormone stimulation in high prolactin, PCOS and low testosterone with type 2 diabetes. Clinical benefits remain unproven. (Studied in a trial) (source)
- Used online for libido and as a proposed hCG alternative during TRT. Improved fertility or sexual function has not been established for KP-10. (Reported by users) (source)
- Investigated for oxytocin and vasopressin diagnostic testing; this does not establish a treatment for either deficiency. (Studied in a trial) (source)
Related to Kisspeptin-10
- Gonadorelin: A short-acting fertility hormone used in tests and specialist pump therapy.
- hCG: A fertility hormone with limited testosterone add-on evidence and no proven weight-loss benefit.
- Bremelanotide: An as-needed injection for low libido before menopause; nausea is common.
- Hexarelin: A peptide that releases growth hormone; repeated use can weaken the response.
Sources
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2026
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, FDA · FDA · 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA · FDA · 2026
- Concerns regarding the public health risks associated with unapproved peptide products, Therapeutic Goods Administration and Chief Medical Officer · Therapeutic Goods Administration · 2026
- Medicines, European Medicines Agency · European Medicines Agency · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026, Australian Government · Australian Government · 2026
- Supply unlicensed medicinal products (specials), MHRA · 2025
- October 29, 2024 Meeting of the Pharmacy Compounding Advisory Committee
- October 29, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting
- Unauthorized injectable peptide drugs seized from Optimum Wellness Centre in Calgary, Alberta may pose serious health risks, Health Canada
- Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men., Yeung AC et al. · European journal of endocrinology · 2026
- Dynamic modulation of LH secretion by continuous kisspeptin infusion in healthy men., Naveed A et al. · Hormones (Athens, Greece) · 2026
- Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans., Galbiati F et al. · Journal of neuroendocrinology · 2026
- Intranasal kisspeptin administration rapidly stimulates gonadotropin release in humans., Mills EG et al. · EBioMedicine · 2025
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.